Founded in 2011 as a spin-off company of the universities and university hospitals of Leuven and Antwerp, icometrix has grown to a team of over 25 people and is internationally active. Their flagship product, MSmetrix, detects brain lesions, calculates lesion volume, and measures whole brain and grey matter volume and atrophy. They are the worldwide standard in MRI biomarkers and have received market approval in the EU and other countries. In addition to their software-as-a-service offering, icometrix also acts as an image analysis expert in clinical trials and research studies, providing fast and high-quality processing of large batches of brain imaging data. They collaborate with healthcare providers and pharmaceutical companies on drug research for neurological disorders.